Timothy C. Barabe

Timothy C. Barabe, listed as board member, has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Cartesian Therapeutics, Inc., Heartflow, Inc. and Acer Therapeutics Inc. Between 31 December 2015 and 22 July 2026, the trades on record add up to 16 filings.

No open-market sale appears; the market trades are 4 purchases worth €331k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 5 share grants and 6 option exercises.

In size, the median ticket on the buying side is €62k. 1 out of 4 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 24 July 2026: an option exercise of €62k, in Heartflow, Inc. The last insider purchase was made public on 8 December 2025, 314 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.